Felipe Pereira

6PUBLICATIONS
59CO-AUTHORS
NanomedicineInfectious agentsOptical technologyAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 23, 2026
The nucleoside analog kamuvudine-9 shows protective and therapeutic efficacy in a mouse model of multiple sclerosis.

|Dec 03, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs.

Shao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara

|Oct 08, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration.

Meenakshi Ambati, Ivana Apicella, Shao-Bin Wang

|Sep 29, 2021
Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity.

Shinichi Fukuda, Siddharth Narendran, Akhil Varshney

|Apr 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration.

Siddharth Narendran, Felipe Pereira, Praveen Yerramothu

|Feb 02, 2021
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration.

Shinichi Fukuda, Akhil Varshney, Benjamin J Fowler

Pageof 1

Frequent Collaborators

5 joint publications

Shao-Bin Wang

5 joint publications

Bradley D Gelfand

5 joint publications

Peirong Huang

4 joint publications

Siddharth Narendran